Verhiest W, Baehre M, Volkers P
Department of Internal Medicine, St. Jozefskliniek, Izegem, Belgium.
Int J Clin Pharmacol Ther Toxicol. 1989 Jul;27(7):342-5.
The efficacy and safety of two combination drugs, consisting of a diuretic + a K-sparing agent, were investigated in the treatment of essential hypertension. A double-blind, randomized, parallel group study design was employed. After randomization, 14 patients were treated with 10 mg xipamide + 30 mg triamterene (A) and 16 with 25 mg hydrochlorothiazide + 50 mg triamterene (B). The patients suffered from essential hypertension with a systolic blood pressure (SBP) at entry of greater than or equal to 150 mmHg and a diastolic blood pressure (DBP) of greater than or equal to 95 mmHg. After 6 weeks, mean decline in DBP was 12% in group A and 9% in group B, respectively. With treatment A, one patient became hypokalemic and with treatment B one patient became hyperkalemic.
研究了两种联合药物(一种利尿剂+一种保钾剂)治疗原发性高血压的疗效和安全性。采用双盲、随机、平行组研究设计。随机分组后,14例患者接受10 mg氯噻嗪+30 mg氨苯蝶啶治疗(A组),16例患者接受25 mg氢氯噻嗪+50 mg氨苯蝶啶治疗(B组)。患者患有原发性高血压,入组时收缩压(SBP)≥150 mmHg,舒张压(DBP)≥95 mmHg。6周后,A组DBP平均下降12%,B组平均下降9%。A组有1例患者出现低钾血症,B组有1例患者出现高钾血症。